Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption
Sheila Connelly(Synthetic Biologics (United States)), Michael Kaleko(Synthetic Biologics (United States)), Joseph Sliman(Synthetic Biologics (United States)), Christian Furlan-Freguia, Poorani Subramanian(National Institute of Allergy and Infectious Diseases), Steve Hubert(Synthetic Biologics (United States)), Andrew Bristol(Synthetic Biologics (United States)), Nur A. Hasan(Universitas Nahdlatul Ulama Indonesia)
Cited by 0
Related Papers
Longitudinal analysis of microbial interaction between humans and the indoor environment
|Science|2014|962
Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic <i>Vibrio cholerae</i>
|Proceedings of the National Academy of Sciences|2009|394
Comprehensive benchmarking and ensemble approaches for metagenomic classifiers
|Genome biology|2017|389
Temperature regulation of virulence factors in the pathogen <i>Vibrio coralliilyticus</i>
|The ISME Journal|2011|294